Epicardial ECM Isolation for Native 3D Cell Culture Matrices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for obtaining and using extracellular matrix (ECM) for cell culture studies face challenges such as uncontrolled variability, limited availability, and the need for large animal sources, which complicates the study of epicardial-derived ECM, especially due to the limited cell number and short half-life of primary epicardial cultures, and existing cell lines do not adequately replicate the native properties of the ventricular epicardium.

Innovation Solution

The development of the EPIC cell line, which is an immortalized cell line derived from embryonic epicardium, provides a source for ECM that better replicates native structural and molecular properties, and a method of isolating ECM using NH4OH de-cellularization to preserve its native three-dimensional structure, allowing for improved cell culture applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If de-cellularised ECM from whole organs is used, then native ECM architecture is preserved, but uncontrolled variability and limited tissue source availability weaken its viability

Engineering Contradiction:
Improvenative ECM architectureVSAvoidcontrolled variability
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The invention segments the ECM source from whole organs to specific cell types (epicardial cells). Instead of using de-cellularised whole heart tissue which has uncontrolled variability, the patent isolates and cultures pure epicardial cells to produce ECM with controlled and defined composition, while still maintaining native architectural features through the specific cell lineage's natural ECM production.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention creates a controlled copy of native ECM by using immortalized epicardial cell lines that naturally produce ECM with native-like composition and architecture. This copying approach through cell culture allows reproduction of native ECM properties without the variability and availability issues of whole organ sources.

Inventive Principle:
Principle #26Copying

2Stability of the object's composition

If native proteins from primary cultures are used, then cellular microenvironment is better preserved, but a large number of animals are required which violates the 3Rs principle

Engineering Contradiction:
Improvecellular microenvironmentVSAvoidnumber of animals required
Core Design Contradiction:
Stability of the object's compositionVSQuantity of substance

Solution Approach 1:

The invention performs preliminary action by establishing immortalized epicardial cell lines that can be expanded and stored indefinitely. This allows accumulation of sufficient ECM material from a single cell line source without needing to harvest from multiple animals, thus reducing animal usage while preserving the native cellular microenvironment characteristics.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The immortalized epicardial cell lines serve themselves by continuously producing ECM with native microenvironment properties. A single established cell line can generate unlimited amounts of ECM material through self-renewal and proliferation, eliminating the need for continuous animal harvesting while maintaining composition stability.

Inventive Principle:
Principle #25Self-service

3Quantity of substance

If existing epicardium-derived cell lines are used, then sufficient ECM quantity can be obtained, but they do not adequately replicate the native properties of the ventricular epicardium

Engineering Contradiction:
ImproveECM quantityVSAvoidnative properties replication
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The invention changes the key parameter of cell line origin and characteristics. Instead of using existing epicardium-derived cell lines with altered properties, the patent employs immortalized cells directly from ventricular epicardium that maintain native phenotypic and molecular characteristics. This parameter change ensures both sufficient ECM production and faithful replication of native ventricular epicardium properties.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ECM derived from the EPIC cell line exhibits enhanced angiogenic and proliferative properties, outperforming commercial matrices like Matrigel in cell culture growth and retention, and can be used for cardiac conditions such as cardiac wall repair.

Implementation Method 1

a method for obtaining it, and its use

Methodology Applied
Scientific EffectDe-cellularization:

Data Source

PatentEP4674951A1Murine extracellular matrix and use thereof in cell cultures
Publication Date: 2026.01.07 UNIV DE MALAGA
  • EP4674951A1 patent drawingFigure 1i~1iii'
  • EP4674951A1 patent drawingFigure 2~3
  • EP4674951A1 patent drawingFigure 4

AI summary

The present invention relates to an extracellular matrix obtained from an EPIC murine cell line, the method of obtaining same and uses in cell cultures.